Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

NCT05769153 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration (nAMD)

Interventions

DRUG: AR-14034 SR implant lower dose
DRUG: AR-14034 SR implant higher dose
DRUG: AR-14034 SR implant
DRUG: Aflibercept Injection
DRUG: Sham procedure

Sponsor

Alcon Research